U.S. Stock Movement Update: Agape ATP surges 87%, Oriental Culture plummets 79%, multiple stocks show significant movement

Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the past hour, with technology and pharmaceutical stocks performing particularly well. Small-cap stocks and thematic stocks have experienced large fluctuations, with noticeable capital inflows. Market sentiment is relatively active, with short-term enthusiasm rising, and some individual stocks have shown significant price movements. The stock with the largest abnormal movement in the last hour is Agape ATP, which surged 87.35%, with trading volume significantly increasing and short-term capital inflows evident, leading to heightened market sentiment. Strong stocks include: 1. SMX Security Matters: up 67.70%, with a 10-day increase of 1113.76%, driven significantly by short-term capital. 2. Grande: up 59.08%, with a 5-day increase of 58.77%, gaining market attention. 3. HeartBeam: up 52.91%, with a 6-month increase of 51.28%, showing clear capital inflows. 4. Velo3D: up 38.26%, with increased trading volume and active short-term capital. 5. Mawson Infrastructure: up 37.54%, with increased trading volume and positive market sentiment. 6. Treasure Gbl: up 26.62%, with increased trading volume driven by short-term capital. 7. CapsoVision: up 25.59%, with increased trading volume and heightened market attention. 8. Nextdoor: up 25.34%, reaching a new 60-day high, with noticeable capital inflows

U.S. Stock Market Midday Update: CapsoVision has risen 187.59% year-to-date, with active capital inflow attracting market attention

CapsoVision rose 21.86%; HoloCare's transaction volume reached 238 million USD; Intuitive Surgical fell 1.58%, with a transaction volume of 217 million USD; Stryker rose 0.70%, with a transaction volume of 175 million USD; Abbott rose 0.80%, with a market value of 214.8 billion USD

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

SARATOGA, Calif., Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- CapsoVision, Inc. ( NASDAQ: CV ) , a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, ...

CapsoVision Reports Revenue Growth and Strategic Advances

CapsoVision, Inc. reported a 19% revenue increase in Q3 2025, with $3.5 million in revenue and a $1.9 million gross profit. The company completed an IPO, raising $23.4 million, and is advancing in product development and partnerships. Despite a $7.9 million net loss, CapsoVision is focused on expanding its product pipeline and has appointed David Garcia as SVP of Finance. Strategic moves include an FDA application for a Breakthrough Device and a development agreement with Canon Inc. for imaging technology.

CapsoVision | 10-Q: FY2025 Q3 Revenue: USD 3.538 M